New research suggests military personnel who suffer more than one mild TBI face a significantly higher risk of suicide.
Researchers discover a connection between the quantity of CB1 cannabinoid receptors in the brain and PTSD.
Researchers note reduced fear and stress responses following a mildly traumatic event when rapamycin, a protein synthesis blocker, is administered.
During the first few months after breast cancer diagnosis, 23 percent of women reported symptoms associated with PTSD, a new study reports.
Police and Firefighters in Early Career at Higher Risk for Mental Disorders Following Traumatic Events
Researchers have discovered new protective service workers, such as police officers and fire fighters, who are repeatedly exposed to traumatic events are at greater risk of developing mental health disorders.
Through a combination of genetic and psychological testing, researchers have identified factors that mitigate against PTSD. In combat, soldiers who avoided threats were more likely to develop PTSD as a result of traumatic experiences, the study found.
A new study provides proof that the amygdala is not the only gatekeeper of fear in the human brain. Other regions, such as the brainstem, diencephalon, or insular cortex, could sense the body’s most primal inner signals of danger when basic survival is threatened.
A new survey of stroke survivors has shown that those with post-traumatic stress disorder (PTSD) are less likely to adhere to treatment regimens that reduce the risk of an additional stroke.
Researchers identified a potential medical treatment for cognitive effects of stress-related disorders, including post-traumatic stress disorder (PTSD). The study, conducted in a PTSD mouse model, shows that an experimental drug called S107, one of a new class of small-molecule compounds called Rycals, prevented learning and memory deficits associated with stress-related disorders.